Ionis Pharmaceuticals, Inc. (IONS) Management Presents at BMO 2020 Prescriptions for Success Healthcare Conference TranscriptSeeking Alpha • 06/23/20
Ionis Pharmaceuticals' (IONS) CEO Brett Monia on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 05/06/20
Ionis Pharmaceuticals' (IONS) CEO Brett Monia on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 02/26/20
Ionis Pharmaceuticals (IONS) Q4 Earnings and Revenues Surpass EstimatesZacks Investment Research • 02/26/20
Akcea and Ionis Confirm Positive Trial Results for Hypertriglyceridemia TreatmentThe Motley Fool • 01/29/20
Akcea and Ionis' Triglyceride-Lowering Drug Works in Mid-Stage Clinical TrialThe Motley Fool • 01/22/20
Will These Biotechs Rival A Top-Notch Stock In High Triglycerides?Investors Business Daily • 01/22/20
Akcea and Ionis Announce Initiation of CARDIO-TTRansform Phase 3 Clinical Trial for AKCEA-TTR-LRx in Patients with TTR-mediated Amyloid CardiomyopathyGlobeNewsWire • 01/10/20
Akcea and Ionis Announce Initiation of NEURO-TTRansform Phase 3 Clinical Trial for AKCEA-TTR-LRx in Patients with Polyneuropathy Driven by Hereditary TTR AmyloidosisGlobeNewsWire • 11/25/19
Surging Earnings Estimates Signal Upside for Ionis Pharmaceuticals (IONS) StockZacks Investment Research • 11/20/19